Vera Therapeutics (VERA) Q1 2025 Earnings
VERA·Reported May 6, 2025·Before market open
Diluted EPS came in at $-0.81 (-44.6% YoY), missed the $-0.75 consensus by $0.06.
Diluted EPS
$-0.81missed by $0.06
Consensus: $-0.75
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Vera Therapeutics's Q1 2025 earnings report.
Vera Therapeutics (VERA) reported Q1 2025 earnings on May 6, 2025 before market open.
Vera Therapeutics reported diluted EPS of $-0.81 for Q1 2025.
EPS missed the consensus estimate of $-0.75 by $0.06.
Compared to the same quarter a year prior, diluted EPS declined 44.6% from $-0.56.
You can read the 10-Q periodic report (0000950170-25-064733) directly on SEC EDGAR. The filing index links above go to sec.gov.